epilepsy
Zonegran study could pave way for paediatric licence
September 2, 2011Research and Development, Sales and Marketing Eisai, Zonegran, epilepsy, research and development news
Eisai’s epilepsy drug Zonegran has been found more effective than placebo in children with the neurological condition who have seizures. …
FDA refuses to file Eisai’s epilepsy drug
August 1, 2011Sales and Marketing Eisai, FDA, epilepsy
The FDA has refused to file Eisai’s epilepsy drug perampanel, saying it needs more information for the treatment. The FDA …
GSK’s epilepsy treatment Potiga wins US approval
June 13, 2011Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy
The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …
GSK’s Trobalt launched in UK
May 25, 2011Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine
GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …
GSK and Valeant’s epilepsy treatment approved
April 8, 2011Sales and Marketing GSK, Trobalt, Valeant, epilepsy
The European Commission has granted marketing authorisation for Trobalt, the new epilepsy drug from GSK and Valeant. Trobalt (retigabine) has …
Encouraging data for Eisai epilepsy drug
August 24, 2010Sales and Marketing Eisai, epilepsy, perampanel, phase III, seizures, study 306
A new phase III study for Eisai’s perampanel (E2007) suggests the first-in-class treatment is effective as an adjunctive treatment of …
Slow recovery expected for epilepsy market
May 27, 2010Sales and Marketing Datamonitor, Keppra, UCB, epilepsy
The global market for epilepsy treatments is expected to make a slow recovery after a wave of patent expiries from …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
